63 related articles for article (PubMed ID: 9756858)
21. Microbials for the production of monoclonal antibodies and antibody fragments.
Spadiut O; Capone S; Krainer F; Glieder A; Herwig C
Trends Biotechnol; 2014 Jan; 32(1):54-60. PubMed ID: 24183828
[TBL] [Abstract][Full Text] [Related]
22. Cell-surface expression of Aspergillus saitoi-derived functional α-1,2-mannosidase on Yarrowia lipolytica for glycan remodeling.
Moon HY; Van TL; Cheon SA; Choo J; Kim JY; Kang HA
J Microbiol; 2013 Aug; 51(4):506-14. PubMed ID: 23990303
[TBL] [Abstract][Full Text] [Related]
23. A combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiae.
Parsaie Nasab F; Aebi M; Bernhard G; Frey AD
Appl Environ Microbiol; 2013 Feb; 79(3):997-1007. PubMed ID: 23204425
[TBL] [Abstract][Full Text] [Related]
24. Expression of glycoproteins bearing complex human-like glycans with galactose terminal in Hansenula polymorpha.
Wang H; Song HL; Wang Q; Qiu BS
World J Microbiol Biotechnol; 2013 Mar; 29(3):447-58. PubMed ID: 23136055
[TBL] [Abstract][Full Text] [Related]
25. Unraveling unique structure and biosynthesis pathway of N-linked glycans in human fungal pathogen Cryptococcus neoformans by glycomics analysis.
Park JN; Lee DJ; Kwon O; Oh DB; Bahn YS; Kang HA
J Biol Chem; 2012 Jun; 287(23):19501-15. PubMed ID: 22500028
[TBL] [Abstract][Full Text] [Related]
26. A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway.
Aumiller JJ; Mabashi-Asazuma H; Hillar A; Shi X; Jarvis DL
Glycobiology; 2012 Mar; 22(3):417-28. PubMed ID: 22042767
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of a homogeneous oligosaccharide with 13C labeling by genetically engineered yeast strain.
Kamiya Y; Yamamoto S; Chiba Y; Jigami Y; Kato K
J Biomol NMR; 2011 Aug; 50(4):397-401. PubMed ID: 21698488
[TBL] [Abstract][Full Text] [Related]
28. Essential role of YlMPO1, a novel Yarrowia lipolytica homologue of Saccharomyces cerevisiae MNN4, in mannosylphosphorylation of N- and O-linked glycans.
Park JN; Song Y; Cheon SA; Kwon O; Oh DB; Jigami Y; Kim JY; Kang HA
Appl Environ Microbiol; 2011 Feb; 77(4):1187-95. PubMed ID: 21183647
[TBL] [Abstract][Full Text] [Related]
29. Development of a novel mammalian cell surface antibody display platform.
Zhou C; Jacobsen FW; Cai L; Chen Q; Shen WD
MAbs; 2010; 2(5):508-18. PubMed ID: 20716968
[TBL] [Abstract][Full Text] [Related]
30. Production of therapeutic antibodies with controlled fucosylation.
Yamane-Ohnuki N; Satoh M
MAbs; 2009; 1(3):230-6. PubMed ID: 20065644
[TBL] [Abstract][Full Text] [Related]
31. Paracoccin from Paracoccidioides brasiliensis; purification through affinity with chitin and identification of N-acetyl-beta-D-glucosaminidase activity.
dos Reis Almeida FB; de Oliveira LL; Valle de Sousa M; Roque Barreira MC; Hanna ES
Yeast; 2010 Feb; 27(2):67-76. PubMed ID: 19908201
[TBL] [Abstract][Full Text] [Related]
32. Emerging methods for the production of homogeneous human glycoproteins.
Rich JR; Withers SG
Nat Chem Biol; 2009 Apr; 5(4):206-15. PubMed ID: 19295526
[TBL] [Abstract][Full Text] [Related]
33. Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology.
Jacobs PP; Geysens S; Vervecken W; Contreras R; Callewaert N
Nat Protoc; 2009; 4(1):58-70. PubMed ID: 19131957
[TBL] [Abstract][Full Text] [Related]
34. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
[TBL] [Abstract][Full Text] [Related]
35. Efficient antibody production upon suppression of O mannosylation in the yeast Ogataea minuta.
Kuroda K; Kobayashi K; Kitagawa Y; Nakagawa T; Tsumura H; Komeda T; Shinmi D; Mori E; Motoki K; Fuju K; Sakai T; Nonaka K; Suzuki T; Ichikawa K; Chiba Y; Jigami Y
Appl Environ Microbiol; 2008 Jan; 74(2):446-53. PubMed ID: 18039826
[TBL] [Abstract][Full Text] [Related]
36. Regulation of methanol utilisation pathway genes in yeasts.
Hartner FS; Glieder A
Microb Cell Fact; 2006 Dec; 5():39. PubMed ID: 17169150
[TBL] [Abstract][Full Text] [Related]
37. Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery.
Sakuraba H; Chiba Y; Kotani M; Kawashima I; Ohsawa M; Tajima Y; Takaoka Y; Jigami Y; Takahashi H; Hirai Y; Shimada T; Hashimoto Y; Ishii K; Kobayashi T; Watabe K; Fukushige T; Kanzaki T
J Hum Genet; 2006; 51(4):341-352. PubMed ID: 16532254
[TBL] [Abstract][Full Text] [Related]
38. Monitoring of the tissue distribution of fibroblast growth factor containing a high mannose-type sugar chain produced in mutant yeast.
Takamatsu S; Chiba Y; Ishii T; Nakayama K; Yokomatsu-Kubota T; Makino T; Fujibayashi Y; Jigami Y
Glycoconj J; 2004; 20(6):385-97. PubMed ID: 15238703
[TBL] [Abstract][Full Text] [Related]
39. In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris.
Vervecken W; Kaigorodov V; Callewaert N; Geysens S; De Vusser K; Contreras R
Appl Environ Microbiol; 2004 May; 70(5):2639-46. PubMed ID: 15128513
[TBL] [Abstract][Full Text] [Related]
40. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris.
Choi BK; Bobrowicz P; Davidson RC; Hamilton SR; Kung DH; Li H; Miele RG; Nett JH; Wildt S; Gerngross TU
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5022-7. PubMed ID: 12702754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
